On March 25, 2020 Senator Blackburn called on the United States to rebuild its domestic pharmaceutical manufacturing capacity in order to end China’s monopoly on the drugs Americans rely on.
Senator Martha Blackburn (R - Tennessee) as prime sponsor to the bipartisan S.3432 - Securing America's Medicine Cabinet Act of 2020. A bill to support the advanced manufacturing technologies program of the Food and Drug Administration, to establish National Centers of Excellence in Advanced Pharmaceutical Manufacturing, and for other purposes.
I would argue it is time for America to sever its pharmaceutical ties and reliance on China. The days of free-trade with China must come to an end, our country must regain control of its supply of pharmaceuticals, among other products.
Why? Prior to the Nixon Administration, the United States had no real relation with China, not even an embassy existed. President Nixon opened China up for dialogue and later on President Clinton gave China equal trading agreements. The middle class worker was then shafted by big business and government bureaucracy & on top of that the United States was trading at a deficit with these deals. That came to an end with the election of President Trump. All existing agreements and ties with China must be ended for America’s sustainability, including our reliance on pharmaceuticals.
China is not a friend of ours but rather an enemy. Senator Blackburn is right on target. This legislation will work toward becoming more independent as a country on pharmaceuticals and should be supported by Americans. Thank you Senator Blackburn for your leadership in sponsoring this act. I am in full support of this legislation.
In my view, we should not accept any supplies or products from China for the foreseeable future.